Medtronic (MDT) Stock Forecast & Price Target

$88.13

-0.50 (-0.56%)

(As of 09/18/2024 ET)

Medtronic - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 15 Analyst Ratings

Based on 15 Wall Street analysts who have issued ratings for Medtronic in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 1 has given a sell rating, 9 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for MDT.

Consensus Price Target

$92.92
5.44% Upside

High Forecast	$106.00
Average Forecast	$92.92
Low Forecast	$83.00

According to the 15 analysts' twelve-month price targets for Medtronic, the average price target is $92.92. The highest price target for MDT is $106.00, while the lowest price target for MDT is $83.00. The average price target represents a forecasted upside of 5.44% from the current price of $88.13.

Type	Current Forecast 9/20/23 to 9/19/24	1 Month Ago 8/21/23 to 8/20/24	3 Months Ago 6/22/23 to 6/21/24	1 Year Ago 9/20/22 to 9/20/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	3 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)
Hold	9 Hold rating(s)	7 Hold rating(s)	5 Hold rating(s)	7 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$92.92	$91.30	$93.00	$91.67
Forecasted Upside	5.44% Upside	12.46% Upside	11.78% Upside	10.80% Upside

Weird phenomenon on AMZN stock (Ad)

What would you do if you knew that you could have bought Amazon on May 25th every year and walked away with a win?

Click here to see the 10 best trades upcoming in 2024 for FREE

MDT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Medtronic Stock vs. The Competition

Type	Medtronic	Medical Companies	S&P 500
Consensus Rating Score	2.33	2.77	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	5.44% Upside	1,009.46% Upside	7.94% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/23/2024	Daiwa America 0 of 5 stars	R. Department Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/23/2024	Truist Financial 1 of 5 stars		Boost Target	Hold ➝ Hold	$85.00 ➝ $90.00	+2.13%
8/22/2024	Barclays 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$104.00 ➝ $105.00	+19.09%
8/21/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $90.00	+4.41%
8/21/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$105.00 ➝ $106.00	+22.67%
8/21/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Sector Perform ➝ Sector Perform	$92.00 ➝ $92.00	+6.47%
China Stockpiling Gold “Like No Tomorrow” (Ad) For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… . Click here now to get your free 'De-Dollarization' Guide.
8/21/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$85.00 ➝ $87.00	+1.90%
8/21/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$82.00 ➝ $90.00	+5.41%
8/21/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$92.00 ➝ $94.00	+10.10%
8/20/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold
8/15/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Antalffy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral	$76.00 ➝ $90.00	+10.12%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$90.00 ➝ $85.00	+10.30%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$83.00	+1.84%
2/21/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$95.00 ➝ $98.00	+14.71%
11/22/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$104.00 ➝ $98.00	+24.68%
6/30/2023	22nd Century Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Initiates
6/30/2023	CL King Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$106.00	+22.16%
5/26/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$100.00 ➝ $99.00	+18.51%
2/22/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$80.00 ➝ $87.00	+1.12%
11/23/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$117.00 ➝ $90.00	+13.92%
10/12/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$87.00	+6.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:23 AM ET.

MDT Forecast - Frequently Asked Questions

What is Medtronic's forecast for 2024?: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Medtronic is $92.92, with a high forecast of $106.00 and a low forecast of $83.00.
Should I buy or sell Medtronic stock right now?: 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There is currently 1 sell rating, 9 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
Does Medtronic's stock price have much upside?: According to analysts, Medtronic's stock has a predicted upside of 10.24% based on their 12-month stock forecasts.
Has Medtronic been upgraded or downgraded by Wall Street analysts recently?: Over the previous 90 days, Medtronic's stock had 2 upgrades and 1 downgrade by analysts.
What analysts cover Medtronic?: Medtronic has been rated by research analysts at Barclays, Citigroup, Daiwa America, Needham & Company LLC, Oppenheimer, Piper Sandler, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Medtronic more than its competitors?: Analysts like Medtronic less than other "medical" companies. The consensus rating for Medtronic is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MDT compares to other companies.